Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_assertion description "[Combination treatment with 4-1BBL/anti-CD20 fusion protein and anti-CD3/anti-CD20 diabody led to significantly increased T-cell cytotoxicity to human B-lymphoma cells in vitro and drastically more potent tumor inhibitory activity in vivo in xenografted B-cell lymphoma in severe combined immunodeficiency disease mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_assertion evidence source_evidence_literature NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_assertion SIO_000772 20463597 NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_assertion wasDerivedFrom befree-20150227 NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_assertion wasGeneratedBy ECO_0000203 NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.
- befree-20150227 importedOn "2015-02-27" NP291072.RAUhjJnlOGF_PjDDU5HNMYbp-awYLFPJ2GQgyllUxMULo130_provenance.